 MIAMI, May 24, 2021 GLOBE NEWSWIRE -- OPKO Health, Inc. NASDAQ: OPK today announced a transfer of the licensed rights to RAYALDEE in Japan from Japan Tobacco Inc. JT to Vifor Fresenius Medical Care Renal Pharma VFMCRP. 